Medigene AG (MDGEF)

USD 2.59

(0.0%)

Long Term Debt Summary of Medigene AG

  • Medigene AG's latest annual long term debt in 2023 was 2.03 Million EUR , down -25.86% from previous year.
  • Medigene AG's latest quarterly long term debt in 2024 Q2 was 1.61 Million EUR , down 0.0% from previous quarter.
  • Medigene AG reported annual long term debt of 2.74 Million EUR in 2022, down -12.44% from previous year.
  • Medigene AG reported annual long term debt of 3.13 Million EUR in 2021, down -21.44% from previous year.
  • Medigene AG reported quarterly long term debt of 2.03 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Medigene AG reported quarterly long term debt of - EUR for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Medigene AG (2023 - 2012)

Historical Annual Long Term Debt of Medigene AG (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 2.03 Million EUR -25.86%
2022 2.74 Million EUR -12.44%
2021 3.13 Million EUR -21.44%
2020 3.99 Million EUR -6.86%
2019 4.28 Million EUR 418.26%
2018 827 Thousand EUR -87.32%
2017 6.52 Million EUR -30.73%
2016 9.41 Million EUR -11.2%
2015 10.6 Million EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%

Peer Long Term Debt Comparison of Medigene AG

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 90.263%
Evofem Biosciences, Inc. 8000.00 USD -25350.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD -15.98%
Mesoblast Limited 100.29 Million USD 97.97%
Propanc Biopharma, Inc. 58.64 Thousand USD -3371.914%
Genus plc 228.2 Million USD 99.108%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD -205.188%
ContraFect Corporation 2.21 Million USD 7.873%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -45.124%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 62.48%
MultiCell Technologies, Inc. 36.43 USD -5588700.439%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 96.339%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 8.535%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -65.749%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 98.774%
Oncotelic Therapeutics, Inc. 1.89 Million USD -7.244%
Skye Bioscience, Inc. 171.23 Thousand USD -1089.044%
Therapeutic Solutions International, Inc. 5512.00 USD -36837.591%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 92.569%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -532.298%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.982%
Halberd Corporation 150 Thousand USD -1257.333%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD -578.667%
Nuo Therapeutics, Inc. 164.2 Thousand USD -1139.914%
argenx SE 15.35 Million USD 86.74%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 89.976%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -45591.203%
Genscript Biotech Corporation 287.12 Million USD 99.291%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1512.009%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -787.955%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -267.118%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -7947.749%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 75.363%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -666.465%
ONE Bio Corp. 592.19 Thousand USD -243.804%
Reve Technologies, Inc. 1064.00 USD -191253.383%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1260.835%
Regen BioPharma, Inc. 149.61 Thousand USD -1260.835%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -786.408%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -1343.972%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -2445.0%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 73.964%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -451.688%
International Stem Cell Corporation 445 Thousand USD -357.528%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 75.018%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -345.514%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -75.366%
PureTech Health plc 18.25 Million USD 88.844%
Coeptis Therapeutics, Inc. 150 Thousand USD -1257.333%
IXICO plc 275 Thousand USD -640.364%
IntelGenx Technologies Corp. 11.83 Million USD 82.803%
Gelesis Holdings, Inc. 26.3 Million USD 92.261%
CSL Limited 11.23 Billion USD 99.982%
Cellectis S.A. 36.21 Million USD 94.377%